| 1 |
任成山，王关嵩，钱桂生. 慢性阻塞性肺疾病的成因及其治疗的困惑与希望[J/CD]. 中华肺部疾病杂志(电子版), 2019, 12(2): 127-141.
|
| 2 |
Adcock IM, Tsaprouni L, Bhavsar P, et al. Epigenetic regulation of airway inflammation[J]. Curr Opin Immunol, 2007, 19(6): 694-700.
|
| 3 |
Tamimi A, Serdarevic D, Hanania NA. The effects of cigarette smoke on airway inflammation in asthma and COPD: therapeutic implications[J]. Respir Med, 2012, 106(3) ：319-328.
|
| 4 |
Cheng SE, Luo SF, Jou MJ, et al. Cigarette smoke extract induces cytosolic phospholipase A2 expression via NADPH oxidase, MAPKs, AP-1, and NF-kappaB in human tracheal smooth muscle cells[J]. Free Radic Biol Med, 2009, 46(7): 948-960.
|
| 5 |
Gan LX, Li CY, Guo XJ, et al. Curcumin modulates the effect of histone modification on the expression of chemokines by type Ⅱ alveolar epithelial cells in a rat COPD model[J]. Int J Chron Obstruct Pulmon Dis, 2016, 11: 2765-2773.
|
| 6 |
甘丽杏，李成业，郭雪君. 慢性阻塞性肺疾病组蛋白去乙酰化酶与糖皮质激素抵抗[J]. 国际呼吸杂志，2010, 30 (5): 283-285.
|
| 7 |
Barnes PJ. Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease[J]. J Allergy Clin Immunol, 2013, 131(3): 636-645.
|
| 8 |
Meja KK, Rajendrasozhan S, Adenuga D, et al. Curcumin Restores Corticosteroid Function in Monocytes Exposed to Oxidants by Maintaining HDAC2[J]. Am J Respir Cell Mol Biol, 2008, 39 (3): 312-323.
|
| 9 |
Barnes PJ. Role of HDAC2 in the pathophysiology of COPD[J]. Annu Rev Physiol, 2009, 71: 451-464.
|
| 10 |
Zhang M, Xie Y, Yan R, et al. Curcumin ameliorates alveolar epithelial injury in a rat model of chronic obstructive pulmonary disease[J]. Life Sci, 2016, 1(164): 1-8.
|
| 11 |
Tang F, Ling C. Curcumin ameliorates chronic obstructive pulmonary disease by modulating autophagy and endoplasmic reticulum stress through regulation of SIRT1 in a rat model[J]. J Int Med Res, 2019, 47(10): 4764-4774.
|
| 12 |
Barnes PJ, Adcock IM. Glucocorticoid resistance in inflammatory diseases[J]. Lancet, 2009, 373(9678): 1905-1917.
|
| 13 |
中华医学会呼吸病学慢性阻塞性肺疾病组. 慢性阻塞性肺疾病诊治指南(2007年修订版)[J]．中华内科杂志，2007, 46(43): 254-261.
|
| 14 |
慢性阻塞性肺疾病急性加重(AECOPD)诊治专家组[J]. 国际呼吸杂志，2017, 37(14): 1041-1057
|
| 15 |
Seemungal TA, Harper-owen R, Bhowmik A, et al. Detection of rhinovirus in induced sputum at exacerbation of chronic obstructive pulmonary disease[J]. Eur Respir J, 2000, 16(4): 677-683.
|
| 16 |
杨 阳，杨 雁. COPD缓解期患者血清PCT、IL-6、hs-CRP水平对急性加重的预测作用[J]. 广东医学，2017, 38(10): 1531-1533.
|
| 17 |
王 飞，贺 蓓. 组蛋白去乙酰化酶在慢性阻塞性肺疾病中的重要作用[J]. 国际呼吸杂志，2007, 27(13): 985-988.
|
| 18 |
Ito K, Jazrawi E, Cosio B, et al. p65-activated histone acetyltransferase activity is repressed by glucocorticoids: mifepristone fails to recruit HDAC2 to the p65-HAT complex[J]. J Biol Chem, 2001, 276(32): 30208-30215.
|
| 19 |
Rahman I, Adcock IM. Oxidative stress and redox regulation of lung inflammation in COPD[J]. Eur Respir J, 2006, 28(1): 219-242.
|
| 20 |
Ito K, Chung KF, Adcock IM. Update on glucocorticoid action and resistance[J]. Allergy Clin Immunol, 2006, 117(3): 522-543.
|
| 21 |
Hull EE, Montgomery MR, Leyva KJ. HDAC2 inhibitors as epigenetic regulators of the immune system: impacts on cancer therapy and inflammatory diseases[J]. Biomed Res Int, 2016, 2016: 8797206.
|
| 22 |
Ito K, Ito M, Elliott WM, et al. Decreased histone deacetylase activity in chronic obstructive pulmonary disease[J]. N Engl J Med, 2005, 352(19): 1967-1976.
|
| 23 |
Barnes P, Ito K, Adcock IM. A mechanism of corticosteroid resistance in COPD: inactivation of histone deacetylase[J]. Lancet, 2004, 363 (9410): 731-733.
|